Methods: We systematically searched PubMed, EMBASE, Cochrane CENTRAL, and Google
Scholar for eligible randomized controlled trials (RCTs) comparing IV iron replacement …

Background Parenteral iron preparations, like ferric carboxymaltose (FCM), are commonly
used to manage moderate-to-severe iron deficiency anemia (IDA). Real-world data on …

Introduction Anemia remains a prevalent global health issue with varying severity.
Intravenous iron supplementation, particularly with ferric carboxymaltose (FCM), has …

Background. Real‐world evidence of the efficacy and safety of ferric carboxymaltose (FCM)
infusion in Indian pregnant women with iron deficiency anemia (IDA) is lacking. Objective …

Results The pre-treatment ferritin and Hb significantly increased from 10.3±2.3 µg/l and
7.99±0.6 g/dl, respectively, to 139.5±1.9 and 14.04±0.45, respectively, 6-weeks after FCM …

Background There is limited clinical evidence of ferric carboxymaltose injection (FCM)
usage in Indian pregnant women. We assessed the efficacy and safety of FCM in Indian …

Iron deficiency anemia (IDA) during pregnancy arises because of preexisting inadequate
stores or complex physiological changes and can lead to serious maternal and fetal …

Background Iron absorption is disturbed after Roux-en-Y gastric bypass (RYGB) and iron
deficiency with or without anaemia affects almost half of all patients. Intravenous iron is an …

Background. Infusion of ferric carboxymaltose (FCM) can correct iron deficiency anaemia in
the second or third trimester of pregnancy. However, large-scale public health use of FCM is …

Iron deficiency (ID) and ID anemia (IDA) pose significant public health concerns in China.
Although iron sucrose (IS) treatment is well-established in the country, ferric carboxymaltose …